We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLH icon
226
Clean Harbors
CLH
$16.2B
$10.8M 0.07%
151,398
+132,976
+722% +$9.26M
AZPN
227
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$10.7M 0.07%
86,384
-43,176
-33% -$5.37M
ZNGA
228
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$10.7M 0.07%
1,745,641
-123,325
-7% -$727K
GRP.U
229
DELISTED
Granite Real Estate Investment Trust
GRP.U
$10.7M 0.07%
231,769
+143,640
+163% +$6.62M
VICI icon
230
VICI Properties
VICI
$29.4B
$10.7M 0.07%
+484,112
New +$10.8M
EFOR
231
Everforth Inc
EFOR
$1.34B
$10.5M 0.07%
172,832
+66,496
+63% +$3.99M
AROC icon
232
Archrock
AROC
$5.85B
$10.4M 0.06%
984,363
-84,489
-8% -$831K
NTAP icon
233
NetApp
NTAP
$37.4B
$10.4M 0.06%
168,732
+48,738
+41% +$3.29M
PTEN icon
234
Patterson-UTI
PTEN
$3.8B
$10.4M 0.06%
902,828
+516,611
+134% +$6.65M
MRCY icon
235
Mercury Systems
MRCY
$6.57B
$10.3M 0.06%
+146,556
New +$10.2M
QDEL icon
236
QuidelOrtho
QDEL
$848M
$10.2M 0.06%
172,510
+138,020
+400% +$8.28M
TRU icon
237
TransUnion
TRU
$15.3B
$10.2M 0.06%
138,870
+74,198
+115% +$5.08M
NDAQ icon
238
Nasdaq
NDAQ
$53B
$10.2M 0.06%
316,818
+276,447
+685% +$8.47M
AIN icon
239
Albany International
AIN
$1.77B
$10.1M 0.06%
121,459
+120,626
+14,481% +$9.03M
ETFC
240
DELISTED
E*Trade Financial Corporation
ETFC
$10M 0.06%
224,827
-81,785
-27% -$3.91M
CRWD icon
241
CrowdStrike
CRWD
$216B
$9.94M 0.06%
+582,128
New +$9.9M
CSTM icon
242
Constellium
CSTM
$4.04B
$9.91M 0.06%
987,633
+100,599
+11% +$931K
CMG icon
243
Chipotle Mexican Grill
CMG
$41.7B
$9.89M 0.06%
674,950
+236,400
+54% +$3.33M
RTLR
244
DELISTED
Rattler Midstream LP Common Units
RTLR
$9.74M 0.06%
+502,251
New +$9.62M
AMED
245
DELISTED
Amedisys
AMED
$9.68M 0.06%
+79,757
New +$9.47M
ADPT icon
246
Adaptive Biotechnologies
ADPT
$3.94B
$9.64M 0.06%
+199,500
New +$8.84M
AME icon
247
Ametek
AME
$58B
$9.56M 0.06%
105,275
-332,711
-76% -$28.5M
FAF icon
248
First American
FAF
$7.62B
$9.37M 0.06%
174,466
+21,532
+14% +$1.17M
CISN
249
DELISTED
Cision Ltd. Ordinary Share
CISN
$9.35M 0.06%
+796,616
New +$9.44M
LKQ icon
250
LKQ Corp
LKQ
$6.28B
$9.34M 0.06%
+350,902
New +$9.82M

Similar funds

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.